Brian B. Gourlie

Person

Midland, MI, US

People

Patents Grantslast 30 patents

Information Patent Grant
Probing method for identifying antibodies specific for selected ant...
- Patent number 6,641,999
- Issue date Nov 4, 2003
- The Dow Chemical Company
- Peter S. Mezes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Family of high affinity, modified antibodies for cancer treatment
- Patent number 6,207,815
- Issue date Mar 27, 2001
- The Dow Chemical Company
- Peter S. Mezes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Family of high affinity, modified antibodies for cancer treatment
- Patent number 6,051,225
- Issue date Apr 18, 2000
- The Dow Chemical Company
- Peter S. Mezes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Family of high affinity, modified antibodies for cancer treatment
- Patent number 5,993,813
- Issue date Nov 30, 1999
- The Dow Chemical Company
- Peter S. Mezes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multivalent single chain antibodies
- Patent number 5,892,020
- Issue date Apr 6, 1999
- The Dow Chemical Company
- Peter S. Mezes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multivalent single chain antibodies
- Patent number 5,877,291
- Issue date Mar 2, 1999
- The Dow Chemical Company
- Peter S. Mezes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Family of anti-carcinoembryonic antigen chimeric antibodies
- Patent number 5,808,033
- Issue date Sep 15, 1998
- The Dow Chemical Company
- Brian B. Gourlie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Family of anti-carcinoembryonic antigen chimeric antibodies
- Patent number 5,472,693
- Issue date Dec 5, 1995
- The Dow Chemical Company
- Brian B. Gourlie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Brian B. Gourlie

Person

Patents Grantslast 30 patents

Probing method for identifying antibodies specific for selected ant...

Family of high affinity, modified antibodies for cancer treatment

Family of high affinity, modified antibodies for cancer treatment

Family of high affinity, modified antibodies for cancer treatment

Multivalent single chain antibodies

Multivalent single chain antibodies

Family of anti-carcinoembryonic antigen chimeric antibodies

Family of anti-carcinoembryonic antigen chimeric antibodies